Share:
Peer-Reviewed Publication
BMC Complement Altern Med2015;15(1):428.December 3, 2015Journal Article

In vitro antiviral activity against rotavirus and astrovirus infection exerted by substances obtained from Achyrocline bogotensis (Kunth) DC. (Compositae).

M A Téllez1, A N Téllez2, F Vélez3, J C Ulloa4
1Laboratorio de Virología, Departamento de Microbiología, Facultad de Ciencias, Grupo de Enfermedades Infecciosas, Pontificia Universidad Javeriana, Cra. 7 # 43-82, Bogotá, Colombia.
2Laboratorio de Fitoquímica, Departamento de Química, Facultad de Ciencias, Grupo de Investigación en Fitoquímica, Pontificia Universidad Javeriana, Bogotá, Colombia.
3Departamento de Matemáticas, Grupo de Investigación Signos, Universidad El Bosque, Bogotá, Colombia.
4Laboratorio de Virología, Departamento de Microbiología, Facultad de Ciencias, Grupo de Enfermedades Infecciosas, Pontificia Universidad Javeriana, Cra. 7 # 43-82, Bogotá, Colombia. julloa@javeriana.edu.co.

Abstract

BACKGROUND: Achyrocline bogotensis has been traditionally used to treat infections of skin, respiratory, tract urinary and other infections, but not to treat viral gastrointestinal disease. In this study, this Colombian native medicinal plant was investigated by its in vitro anti-rotavirus and anti-astrovirus activity. METHODS: Several extracts and fractions phytochemically obtained from A. bogot…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.